Correlation Between Suzhou Novoprotein and Meinian Onehealth

Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Meinian Onehealth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Meinian Onehealth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Meinian Onehealth Healthcare, you can compare the effects of market volatilities on Suzhou Novoprotein and Meinian Onehealth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Meinian Onehealth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Meinian Onehealth.

Diversification Opportunities for Suzhou Novoprotein and Meinian Onehealth

0.88

Correlation Coefficient

Suzhou Novoprotein  Meinian Onehealth

Very poor diversification

The 3 months correlation between Suzhou and Meinian is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Meinian Onehealth Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Meinian Onehealth and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Meinian Onehealth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Meinian Onehealth has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Meinian Onehealth go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Meinian Onehealth

Assuming the 90 days trading horizon Suzhou Novoprotein is expected to generate 2.0 times less return on investment than Meinian Onehealth. But when comparing it to its historical volatility, Suzhou Novoprotein Scientific is 1.0 times less risky than Meinian Onehealth. It trades about 0.11 of its potential returns per unit of risk. Meinian Onehealth Healthcare is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  336.00  in Meinian Onehealth Healthcare on September 3, 2024 and sell it today you would earn a total of  156.00  from holding Meinian Onehealth Healthcare or generate 46.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Suzhou Novoprotein Scientific  vs.  Meinian Onehealth Healthcare

Suzhou Novoprotein

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.

Meinian Onehealth

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Meinian Onehealth Healthcare are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Meinian Onehealth sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Suzhou Novoprotein and Meinian Onehealth

The main advantage of trading using opposite Suzhou Novoprotein and Meinian Onehealth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Meinian Onehealth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Meinian Onehealth will offset losses from the drop in Meinian Onehealth's long position.

The idea behind Suzhou Novoprotein Scientific and Meinian Onehealth Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.